breast cancer Archives

In Depth 3 Aug 2023

How is artificial intelligence rising to the challenge in breast cancer diagnosis?

The scope of artificial intelligence (AI) in medicine has been rapidly expanding in recent years. With AI shaping the way clinical research is conducted, it has also opened doors for…

August 3, 2023 - 9 minutesmins - By Roohi Mariam Peter

Best in Biotech 18 May 2023

Six women’s health companies you should know about

While sexism exists in all strands of society, where in 2023, women earn 77 cents for every dollar earned by men, studies estimate that it will take the world 257…

May 18, 2023 - 8 minutesmins - By Roohi Mariam Peter

Fluorescence microcopy image of gamma delta T cells (green) attacking cancer cells (blue). To get tot he cancer cells, the immune cells need to navigate through a dense extracellular matrix that surrounds the tumor tissue (red). Image: Katrin Raute / University of Freiburg

News and Trends 4 May 2023

Osteoporosis drug helps T cells fight aggressive breast cancer

Researchers in Germany have discovered a mechanism by which cancer cells escape the immune system - and how to reverse it. Triple-negative breast cancer (TNBC) is the most aggressive and…

May 4, 2023 - 3 minutesmins - By Jim Cornall

Vaccines for difficult-to-treat diseases

Best in Biotech 12 Apr 2023

6 new vaccines being developed for difficult-to-treat diseases

There are several promising new vaccine candidates being developed for complex diseases that historically have been extremely difficult to find treatments and cures for. The development of these new vaccines…

April 12, 2023 - 10 minutesmins - By Willow Shah-Neville

From breast to bone: Refining metastasis drug discovery with a novel organ-on-a-chip device

Understanding invasive cancer progression and metastasis formation are among the core open questions in cancer research. However, the limitations of current models lead to high failure rates in drug development.…

February 21, 2023 - 6 minutesmins - By Ute Boronowsky

News and Trends 9 Feb 2023

Cleveland Clinic breast cancer vaccine study moves forward

Researchers from global health system Cleveland Clinic have launched the next step in their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal…

February 9, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 31 Jan 2023

Stemline Therapeutics’ breast cancer treatment approved

The Menarini Group, an Italian pharmaceutical and diagnostics company, says that the U.S. Food and Drug Administration (FDA) has approved ORSERDU for the treatment of postmenopausal women or adult men,…

January 31, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 26 Jan 2023

Ibex to collaborate with AstraZeneca and Daiichi Sankyo on AI breast cancer product

Ibex Medical Analytics has announced an agreement with AstraZeneca and Daiichi Sankyo, for the development, clinical validation and early adoption of an AI-powered product to aid pathologists with an accurate…

January 26, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 12 Jan 2023

Breast cancer most studied disease area in 2022

Phesi, a global provider of patient-centric data analytics, has released the results of its global analysis of all clinical trials conducted in 2022. The report, which analyzed 80,917 trial records, reveals…

January 12, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 9 Jan 2023

ErVaccine raises €4.5M to start therapeutic cancer vaccine trial

ErVaccine Technologies, announces the closing of a €4.5 million ($4.8 million) seed round, including dilutive and non-dilutive funds, with Seventure and Bpifrance as part of the Aide au Développement de…

January 9, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 13 Dec 2022

Therabest and Glycotope to assess breast cancer combination treatment

Therabest USA. Inc, Therabest Korea and Glycotope GmbH have signed an agreement to assess the clinical development of Therabest’s EiNK (enhanced iPSC-derived NK) cell therapy, TB-100, in combination with Glycotope’s…

December 13, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 9 Dec 2022

New targeted drug shows benefit against breast cancer in first phase III trial

A new type of targeted medicine has shown ‘remarkable’ benefits for patients with advanced breast cancer in a major phase III clinical trial. The drug capivasertib combined with hormone therapy…

December 9, 2022 - 7 minutesmins - By Jim Cornall

More News! 8 Dec 2022

Enhertu’s positive results demonstrate improvement in overall survival

Enhertu, an antibody drug conjugate, being jointly developed by Daiichi Sankyo and AstraZeneca, has demonstrated a statistically significant and clinically meaningful improvement in overall survival. Updated results from DESTINY-Breast03 phase…

December 8, 2022 - 4 minutesmins - By Liza Laws

News and Trends 6 Dec 2022

Startup Graegis developing therapies for radiation side-effects

Graegis Pharmaceuticals, a startup developing new therapies aimed at preventing the side effects of radiotherapies, is set to complete the regulatory nonclinical package allowing entry in clinical trials. The company,…

December 6, 2022 - 2 minutesmins - By Liza Laws

News and Trends 3 Nov 2022

Positive results of cancer treatment to be presented at Boston conference

Results of a cancer treatment in the treatment of gynecologic and breast cancer are to be presented next week, November 8-12, at the Society for Immunotherapy of Cancer (SITC) conference…

November 3, 2022 - 2 minutesmins - By Liza Laws

Kintor Pharmaceutical drug gets positive results for breast cancer

News and Trends 29 Sep 2022

Positive results from study of drug to treat patients with breast cancer published

Results from a phase 1b study of a drug to treat patients with androgen receptor positive (AR+) metastatic breast cancer (mBC) in China were published yesterday (September 28). Kintor Pharmaceutical…

September 29, 2022 - 3 minutesmins - By Liza Laws

News and Trends 16 Sep 2022

Ghana first to benefit from Roche partnership with Jhpiego to improve cervical and breast cancer outcomes for women

Roche has signed a memorandum of understanding (MoU) with the Johns Hopkins Program for International Education in Gynecology and Obstetrics (Jhpiego) to improve cervical and breast cancer outcomes in resource-constrained…

September 16, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 12 Sep 2022

Reveal Genomics reveals more HER2DX breast cancer validation data

Reveal Genomics, S.L. says it has received more validation of HER2DX, the world's first specialized genomic test for HER2+ breast cancer. Valentina Guarneri from the University of Padova presented the…

September 12, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 8 Sep 2022

Lutris Pharma radiation trial brings positive results for breast cancer patients

Top line results from a clinical trial treating breast cancer patients with radiation dermatitis (RD) have been positive. Lutris Pharma, based in Israel, is a biopharma company focused on improving…

September 8, 2022 - 4 minutesmins - By Liza Laws

News and Trends 2 Sep 2022

Ibex reports positive outcomes for AI-supported diagnosis of breast cancer

Ibex Medical Analytics have just announced positive outcomes for its Galen Breast solution in diagnosing multiple cancer types and further expanding its portfolio for breast cancer diagnosis. The CE-marked artificial-intelligence…

September 2, 2022 - 4 minutesmins - By Liza Laws

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering